News

Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in ...
It's depressing how homophobia has stood the test of time, but I'm still optimistic about the future,” Randy Barbato says of ...
A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.
The 89th legislative session wrapped up Monday, concluding any business lawmakers have been working on for the past five ...
A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If ...
You can spend Pride disassociating to avoid the news, throwing bricks, or watching selections from a century of queer movies.
AVOL Kentucky told us there was concern about proposed budget cuts at the federal level. Those cuts are now reality after the ...
A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to ...
Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.
The PURPOSE trials illuminated the ways in which lenacapavir could be used as a means of pre-exposure prophylaxis effectively, but also featured several adverse events.
It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, ...
Technology has changed the lives of everyone in today’s current age. From being able to communicate with relatives and loved ones at far distances faster, to being able to throw anything in the air ...